Vaccines, blood, antisera, toxins and cultures in   Republic of the Congo

Exports In 2023, Republic of the Congo exported $13k in Vaccines, blood, antisera, toxins and cultures, making it the 159th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 228th most exported product in Republic of the Congo. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Republic of the Congo are: United States ($9.2k), France ($3.4k), Spain ($256), Uganda ($76), and South Africa ($15).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Republic of the Congo between 2022 and 2023 were United States ($9.2k), France ($1.74k), and Spain ($256).

Imports In 2023, Republic of the Congo imported $37.2M in Vaccines, blood, antisera, toxins and cultures, becoming the 122nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 32nd most imported product in Republic of the Congo. Republic of the Congo imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($34M), India ($2.44M), France ($364k), Indonesia ($195k), and Bulgaria ($36.4k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Republic of the Congo between 2022 and 2023 were India ($1.74M), Indonesia ($195k), and Bulgaria ($36.4k).